The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation• Stanford’s AI Designed Bacteriophages: Ushering in the Next Phase in IP Strategy for Phage Companies?• Breathing Engineered Bacteria: A New Approach to Treating Lung Disease• Vedanta Biosciences Secures $60 Million in Funding Ahead of Pivotal Phase 3 Data• Gut fungi may hold the key to treating Asthma worldwide•

Category: Clinical & Manufacturing

Initial patient dosed in Phase 2a clinical trial evaluating first-in-class human milk-based therapy
Basic & Discovery Research

Initial patient dosed in Phase 2a clinical trial evaluating first-in-class human milk-based therapy

NOV 15, 2023
MaaT Pharma Announces First Patient Dosed in Phase 2b Randomized Clinical Trial Evaluating MaaT033 in Patients Receiving Allo-HSCT
Clinical & Manufacturing

MaaT Pharma Announces First Patient Dosed in Phase 2b Randomized Clinical Trial Evaluating MaaT033 in Patients Receiving Allo-HSCT

NOV 7, 2023
Kanvas Biosciences Acquires Federation Bio Assets to Scale Discovery, Development and Manufacturing
Basic & Discovery Research

Kanvas Biosciences Acquires Federation Bio Assets to Scale Discovery, Development and Manufacturing

OCT 12, 2023
First Patient Dosed in Phase 2 Clinical Trial of Vedanta’s VE202 for the Treatment of Ulcerative Colitis
Clinical & Manufacturing

First Patient Dosed in Phase 2 Clinical Trial of Vedanta’s VE202 for the Treatment of Ulcerative Colitis

OCT 5, 2023
MRM Health Reports Positive Topline Results from Phase 2a Clinical Study with MH002 in Mild-to-Moderate Ulcerative Colitis
Clinical & Manufacturing

MRM Health Reports Positive Topline Results from Phase 2a Clinical Study with MH002 in Mild-to-Moderate Ulcerative Colitis

SEP 19, 2023
Bloom Science Announces Positive Topline Data from a Phase 1 Clinical Trial
Basic & Discovery Research

Bloom Science Announces Positive Topline Data from a Phase 1 Clinical Trial

AUG 18, 2023
Freya Biosciences Announces Positive Topline Clinical Trial Results for FB101 in Women with Asymptomatic Vaginal Dysbiosis
Clinical & Manufacturing

Freya Biosciences Announces Positive Topline Clinical Trial Results for FB101 in Women with Asymptomatic Vaginal Dysbiosis

JUN 28, 2023
FDA Lifts Hold on Maat Pharma’s Phase 3 Investigational NDA for MaaT013
Clinical & Manufacturing

FDA Lifts Hold on Maat Pharma’s Phase 3 Investigational NDA for MaaT013

APR 28, 2023
Vedanta Biosciences Publishes Phase 2 Results
Clinical & Manufacturing

Vedanta Biosciences Publishes Phase 2 Results

APR 18, 2023
Microbiotica Announces Clinical Trial Collaboration with MSD
Basic & Discovery Research

Microbiotica Announces Clinical Trial Collaboration with MSD

APR 13, 2023
Finch Therapeutics Announces Decision to Discontinue Phase 3 Trial of CP101
Clinical & Manufacturing

Finch Therapeutics Announces Decision to Discontinue Phase 3 Trial of CP101

JAN 24, 2023